Pfizer (PFE) Debt Ratio (2009 - 2026)

Pfizer (PFE) has 18 years of Debt Ratio data on file, last reported at 0.31 in Q1 2026.

• Debt Ratio for Q1 2026 came in at 0.31, up 3.79% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.31 (up 3.79% YoY), and the FY2025 annual result was 0.31, up 3.88% from the prior year.
• Debt Ratio held at 0.31 in Q1 2026 per PFE's latest filing, from 0.31 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.89 in Q4 2022 and troughed at 0.18 in Q4 2022.
• A 5-year average of 0.31 and a median of 0.3 in 2024 frame the typical range for Debt Ratio.
• On a YoY basis, Debt Ratio climbed as much as 74.51% in 2023 and fell as far as 66.82% in 2023.
• A 5-year view of Debt Ratio shows it stood at 0.18 in 2022, then jumped by 74.51% to 0.32 in 2023, then slipped by 5.59% to 0.3 in 2024, then increased by 3.88% to 0.31 in 2025, then retreated by 0.45% to 0.31 in 2026.
• Business Quant data shows PFE's Debt Ratio at 0.31 in Q1 2026, 0.31 in Q4 2025, and 0.3 in Q3 2025.